Fin-health startup delivers 30 per cent to 40 per cent cost savings to patients while posting $3 million ARR, positioning for company-wide profitability within four months
Mykare, one of India’s leading fin-health startups revolutionising healthcare accessibility for the missing middle class, has announced that it has achieved EBITDA-positive status in its flagship elective surgery vertical. This milestone comes alongside robust 80per cent year-over-year revenue growth and a current annual recurring revenue (ARR) of $3 million, demonstrating the scalability of its asset-light healthcare model.
The achievement positions Mykare as one of the few profitable players in India’s digital health ecosystem, just three years after the Kerala-headquartered company commenced operations in 2022. With unit economics showing EBITDA margins exceeding 10 per cent and strong operational fundamentals, the company projects achieving company-wide profitability within the next four months.
Senu Sam, Founder and CEO, Mykare, said, “Achieving EBITDA-positive status in our elective surgery vertical proves that purpose-driven healthcare can be both impactful and financially sustainable. This milestone validates our mission to make quality healthcare accessible to India’s underserved middle class, where the vast majority lack adequate insurance coverage. Our success in delivering significant cost savings while maintaining profitability demonstrates the scalability of our model. As we expand with our new Bengaluru office, we’re preparing to launch a comprehensive fin-health vertical targeting India’s large self-employed segment—a population that remains largely uninsured despite representing nearly one-third of the country. The potential here is enormous: our asset-light model allows us to scale rapidly across India’s underserved healthcare landscape. What excites me most is that we’ve proven sustainable unit economics can coexist with meaningful social impact—this positions us to transform healthcare accessibility for millions of Indians.”
